207 related articles for article (PubMed ID: 12623151)
1. Risk factors for adenotonsillar hypertrophy in children following solid organ transplantation.
Shapiro NL; Strocker AM; Bhattacharyya N
Int J Pediatr Otorhinolaryngol; 2003 Feb; 67(2):151-5. PubMed ID: 12623151
[TBL] [Abstract][Full Text] [Related]
2. Adenotonsillar hypertrophy and Epstein-Barr virus in pediatric organ transplant recipients.
Shapiro NL; Strocker AM
Laryngoscope; 2001 Jun; 111(6):997-1001. PubMed ID: 11404611
[TBL] [Abstract][Full Text] [Related]
3. Adenotonsillar enlargement in pediatric organ transplant recipients: a cross-sectional analysis.
Chiang S; Vu MC; Nguyen M; Strocker A; Horvath S; Shapiro N
Otolaryngol Head Neck Surg; 2002 Jul; 127(1):109-14. PubMed ID: 12161739
[TBL] [Abstract][Full Text] [Related]
4. Adenotonsillar enlargement in pediatric patients following solid organ transplantation.
Huang RY; Shapiro NL
Arch Otolaryngol Head Neck Surg; 2000 Feb; 126(2):159-64. PubMed ID: 10680866
[TBL] [Abstract][Full Text] [Related]
5. A review of adenotonsillar hypertrophy and adenotonsillectomy in children after solid organ transplantation.
Roberts J; Powell J; Mather MW; Powell S; Brodlie M
Int J Pediatr Otorhinolaryngol; 2018 Nov; 114():29-35. PubMed ID: 30262363
[TBL] [Abstract][Full Text] [Related]
6. Association between Epstein-Barr virus seroconversion and immunohistochemical changes in tonsils of pediatric solid organ transplant recipients.
Shapiro NL; Tang CG; Bhattacharyya N
Laryngoscope; 2011 Aug; 121(8):1718-25. PubMed ID: 21792960
[TBL] [Abstract][Full Text] [Related]
7. Post-transplantation lymphoproliferative disorders localizing in the adenotonsillar region: report from the PTLD.Int survey.
Khedmat H; Taheri S
Ann Transplant; 2011; 16(1):109-16. PubMed ID: 21436784
[TBL] [Abstract][Full Text] [Related]
8. Adenotonsillar histopathology after organ transplantation.
Williamson RA; Huang RY; Shapiro NL
Otolaryngol Head Neck Surg; 2001 Sep; 125(3):231-40. PubMed ID: 11555759
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical analysis and Epstein-Barr virus in the tonsils of transplant recipients and healthy controls.
Mowry SE; Strocker AM; Chan J; Takehana C; Kalantar N; Bhuta S; Shapiro NL
Arch Otolaryngol Head Neck Surg; 2008 Sep; 134(9):936-9. PubMed ID: 18794437
[TBL] [Abstract][Full Text] [Related]
10. Adenotonsillar pathology in post-transplant patients.
Roy S; Vivero RJ; Smith LP
Int J Pediatr Otorhinolaryngol; 2008 Jun; 72(6):865-8. PubMed ID: 18395271
[TBL] [Abstract][Full Text] [Related]
11. The validity of the OSA-18 among three groups of pediatric patients.
Strocker AM; Carrer A; Shapiro NL
Int J Pediatr Otorhinolaryngol; 2005 Feb; 69(2):241-7. PubMed ID: 15656959
[TBL] [Abstract][Full Text] [Related]
12. Impact of Epstein-Barr virus donor and recipient serostatus on the incidence of post-transplant lymphoproliferative disorder in kidney transplant recipients.
Sampaio MS; Cho YW; Shah T; Bunnapradist S; Hutchinson IV
Nephrol Dial Transplant; 2012 Jul; 27(7):2971-9. PubMed ID: 22273720
[TBL] [Abstract][Full Text] [Related]
13. Risk factors and clinical outcomes of pediatric liver transplant recipients with post-transplant lymphoproliferative disease in a multi-ethnic Asian cohort.
Huang JG; Tan MYQ; Quak SH; Aw MM
Transpl Infect Dis; 2018 Feb; 20(1):. PubMed ID: 29071779
[TBL] [Abstract][Full Text] [Related]
14. Decreasing incidence of symptomatic Epstein-Barr virus disease and posttransplant lymphoproliferative disorder in pediatric liver transplant recipients: report of the studies of pediatric liver transplantation experience.
Narkewicz MR; Green M; Dunn S; Millis M; McDiarmid S; Mazariegos G; Anand R; Yin W;
Liver Transpl; 2013 Jul; 19(7):730-40. PubMed ID: 23696264
[TBL] [Abstract][Full Text] [Related]
15. The Changing Epidemiology of Posttransplant Lymphoproliferative Disorder in Adult Solid Organ Transplant Recipients Over 30 Years: A Single-center Experience.
Peters AC; Akinwumi MS; Cervera C; Mabilangan C; Ghosh S; Lai R; Iafolla M; Doucette K; Preiksaitis JK
Transplantation; 2018 Sep; 102(9):1553-1562. PubMed ID: 29485513
[TBL] [Abstract][Full Text] [Related]
16. Clinical and virologic outcomes in high-risk adult Epstein-Barr virus mismatched organ transplant recipients.
Kumar D; Patil N; Husain S; Chaparro C; Bhat M; Kim SJ; Humar A
Clin Transplant; 2017 Jul; 31(7):. PubMed ID: 28489256
[TBL] [Abstract][Full Text] [Related]
17. Early signs and risk factors for the increased incidence of Epstein-Barr virus-related posttransplant lymphoproliferative diseases in pediatric liver transplant recipients treated with tacrolimus.
Sokal EM; Antunes H; Beguin C; Bodeus M; Wallemacq P; de Ville de Goyet J; Reding R; Janssen M; Buts JP; Otte JB
Transplantation; 1997 Nov; 64(10):1438-42. PubMed ID: 9392308
[TBL] [Abstract][Full Text] [Related]
18. Post-transplant lymphoproliferative disorders with naso- and oropharyngeal manifestation.
Akbas A; Tiede C; Lemound J; Maecker-Kolhoff B; Kreipe H; Hussein K
Transpl Int; 2015 Nov; 28(11):1299-307. PubMed ID: 26147593
[TBL] [Abstract][Full Text] [Related]
19. Complete immunosuppressive withdrawal as a uniform approach to post-transplant lymphoproliferative disease in pediatric liver transplantation.
Hurwitz M; Desai DM; Cox KL; Berquist WE; Esquivel CO; Millan MT
Pediatr Transplant; 2004 Jun; 8(3):267-72. PubMed ID: 15176965
[TBL] [Abstract][Full Text] [Related]
20. Adolescents are more likely to develop posttransplant lymphoproliferative disorder after primary Epstein-Barr virus infection than younger renal transplant recipients.
Smith JM; Corey L; Healey PJ; Davis CL; McDonald RA
Transplantation; 2007 Jun; 83(11):1423-8. PubMed ID: 17565314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
